Axplora is repositioning its Italian Farmabios site on high-potency APIs as UDCA production moves to its FDA-approved Vizag facility in India, consolidating supply and scaling for global demand.
Röhm's LiMA technology is in full industrial operation in Bay City, Texas (USA).
A clear signal to Berlin: the pharmaceutical companies Eli Lilly and Boehringer Ingelheim are canceling planned investments in Germany.
Sasol is expanding its Brunsbüttel site with a €60 million investment to boost specialty alumina production and strengthen supply for critical catalyst applications. Operations targeted for 2029.
Evonik has opened its first center for beauty science and innovation in Asia at the Evonik Shanghai Innovation Park in China.
Northway Biotech is finalizing the Baltic region's most advanced cell therapy center — a 3,500 m² facility at Vilnius City Innovation Industrial Park, set to open Q3 2025.
Covestro has opened its new thermoplastic polyurethanes (TPU) Application Development (AD) Center in Guangzhou, China.
Piramal Pharma Solutions opens a new payload-linker suite in Michigan as part of a $90 million US investment plan, bolstering its ADC manufacturing capabilities across sites in Riverview and Lexington.
Eli Lilly adds $4.5 billion to its Indiana manufacturing programme, funding a new genetic medicine facility and expanded API capacity at Lebanon, taking its total US investment since 2020 past $50 billion.
Abu Dhabi's Ta'ziz signs a $10 billion chemicals deal with Alpha Dhabi and closes $2bn in methanol plant financing, marking over $12 billion in new investment at Al Ruwais Industrial City.
Takeda has officially commissioned a new photovoltaic system at its production site in Oranienburg near Berlin.
BASF Agricultural Solutions has successfully commissioned its BioHub, a new fermentation plant for biological and biotechnology-based crop protection products, at the Ludwigshafen site.
The new building increases metrology and inspection capacity fivefold and supports chip manufacturers in the advanced packaging of AI chips.
On April 22, 2026, Symrise opened its modernized Food & Beverage site in Parets del Vallès near Barcelona.
All closing conditions satisfied for the acquisition of three small molecule sites in the US and Australia; closing to occur as of May 1, 2026. Adds highly demanded US-based manufacturing capacity to Siegfried's network.
Landmark facility to produce low-carbon methanol, supporting the energy transition and creating hundreds of jobs along the Gulf Coast.
New facility serves biopharma manufacturers throughout the region with local access to customer purification studies across Ecolab's Purolite Resin portfolio
The investment, its largest since its inception, demonstrates continued progress against AbbVie's $100 billion commitment to US R&D and capital investments, including manufacturing, over the next decade.
Evonik is expanding its biotechnological production capacities at the Fermas site in Slovenská Ľupča with an investment of around €80 million
Uhde Inventa-Fischer has signed a contract with Köksan for the supply of a PET production plant. The plant will be built in Yumurtalık, Türkiye.
The acquisition marks Samsung Biologics’ geographical diversification, establishing its first US manufacturing presence and expanding regional client support.
The newly constructed Verbund site in Zhanjiang, Guangdong Province in southern China, with an area of around four square kilometers, is more than just a major project for BASF in the growth market of China.
Cambrex is advancing its $150 million investment to expand API manufacturing in Iowa and enhance R&D and manufacturing capabilities in Milan, strengthening its services in the US and Europe.
LGM Pharma invests an additional $9 million to expand US manufacturing, bringing total investment to $15 million across its Texas and Colorado facilities.
Ice Pharma recently announced a strategic expansion beyond its core API business, positioning the company to compete in higher-value finished dosage, nutraceutical, and specialty excipient markets.
Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development in Boulder, Colorado.
$60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy.
Arkema will increase Kynar PVDF production capacity at its Changshu, China site by 20% by 2028 to meet strong demand for batteries, coatings and other high-performance applications in Asia-Pacific and globally.
Metrohm USA opened its new 15,000 sq ft Houston facility on March 24, 2026, marking its shift from leased space to a custom-built, sustainable site supporting technical innovation, training, and regional growth.
Investment marks continued progress against AbbVie's $100 billion commitment to US R&D and capital investments, including manufacturing, over the next decade.
Ineos will invest €300 million, backed by French government grants, to modernise and decarbonise its Lavera site, cutting CO₂ emissions by 331,000 tons annually.
Syensqo is investing about €20 million, with backing from the France 2030 plan, to install a large-capacity electric boiler and other low-carbon infrastructure at its Saint-Fons site.
Axplora announced a multi-million-euro investment to expand lyophilization capabilities at its Le Mans site and appointed François Houbart as Head of Site.
BASF plans to open a global digital hub in Hyderabad in the first quarter of 2026, thereby strengthening the existing global network of digital hubs in EMEA and APAC.
Sharp Services has invested over €20 million to expand injectables packaging capacity at its facilities in Hamont-Achel, Belgium, and Heerenveen, Netherlands, with significant cold chain enhancements.
